Revelation Biosciences, Inc. (REVB) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
REVB Revenue Growth
REVB Revenue Analysis (2019–2025)
As of May 8, 2026, Revelation Biosciences, Inc. (REVB) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, REVB's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ADMA (+11.0% YoY), AGEN (+10.4% YoY), and HALO (+37.6% YoY). Compare REVB vs ADMA →
REVB Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| REVBCurrent | $0 | - | - | - | |
 ADMA | $510M | +11.0% | +64.6% | 37.5% | |
 AGEN | $114M | +10.4% | +5.3% | -18.0% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 NVAX | $1.1B | -52.5% | +118.8% | 50.1% |
REVB Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-27,058 | - | $-9,070,814 | - |
| 2024 | $0 | - | $-27,923 | - | $-7,975,109 | - |
| 2023 | $0 | - | $-25,049 | - | $-8,656,664 | - |
| 2022 | $0 | - | $-40,008 | - | $-10,864,511 | - |
| 2021 | $0 | - | $-69,166 | - | $-11,950,485 | - |
| 2020 | $0 | - | $0 | - | $-3,795,819 | - |
| 2019 | $0 | - | $0 | - | $-3,638 | - |
See REVB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs REVB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare REVB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonREVB — Frequently Asked Questions
Quick answers to the most common questions about buying REVB stock.
Is REVB's revenue growth accelerating or slowing?
REVB TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is REVB's long-term revenue growth rate?
Revelation Biosciences, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is REVB's revenue distributed by segment?
REVB reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.